Patents by Inventor Mehrdad MOBASHER

Mehrdad MOBASHER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING ACUTE MYELOID LEUKEMIA AND MANAGING CYTOPENIA
    Publication number: 20240091248
    Abstract: Provided herein are methods for treating acute myeloid leukemia (AML) in a patient with cytopenia when on a combination therapy of venetoclax and azacitidine. Also provided herein are methods of managing a cytopenia in such patient.
    Type: Application
    Filed: November 3, 2023
    Publication date: March 21, 2024
    Applicants: GENENTECH, INC., ABBVIE INC.
    Inventors: Ahmed Hamed SALEM, Jalaja POTLURI, Jiuhong ZHA, Mehrdad MOBASHER, Wan-Jen HONG
  • METHODS OF TREATING ACUTE MYELOID LEUKEMIA AND MANAGING CYTOPENIA
    Publication number: 20230027184
    Abstract: Provided herein are methods for treating acute myeloid leukemia (AML) in a patient with cytopenia when on a combination therapy of venetoclax and azacitidine. Also provided herein are methods of managing a cytopenia in such patient.
    Type: Application
    Filed: September 15, 2022
    Publication date: January 26, 2023
    Applicants: GENENTECH, INC., ABBVIE INC.
    Inventors: Ahmed Hamed SALEM, Jalaja POTLURI, Jiuhong ZHA, Mehrdad MOBASHER, Wan-Jen HONG
  • METHODS OF TREATING ACUTE MYELOID LEUKEMIA AND MANAGING CYTOPENIA
    Publication number: 20230000889
    Abstract: Provided herein are methods for treating acute myeloid leukemia (AML) in a patient with cytopenia when on a combination therapy of venetoclax and azacitidine. Also provided herein are methods of managing a cytopenia in such patient.
    Type: Application
    Filed: June 7, 2022
    Publication date: January 5, 2023
    Applicants: GENENTECH, INC., ABBVIE INC.
    Inventors: Ahmed Hamed SALEM, Jalaja POTLURI, Jiuhong ZHA, Mehrdad MOBASHER, Wan-Jen HONG
  • TREATMENT OF CD20-POSITIVE B-CELL LYMPHOMA WITH OBITUZUMAB
    Publication number: 20200299398
    Abstract: The present disclosure relates to administration speed of obinutuzumab.
    Type: Application
    Filed: October 19, 2018
    Publication date: September 24, 2020
    Inventors: Michael WENGER, Mehrdad MOBASHER, Chin-Yu LIN